Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.67 USD | -0.54% | +7.94% | -12.83% |
28/05 | CureVac, GSK Begin Dosing in Phase 2 Study for Seasonal Influenza Vaccine Candidate | MT |
23/05 | CureVac N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.83% | 83Cr | |
+54.05% | 6.39TCr | |
-2.02% | 4.18TCr | |
+40.01% | 4.05TCr | |
-10.22% | 2.72TCr | |
+13.42% | 2.65TCr | |
-21.60% | 1.87TCr | |
+2.89% | 1.27TCr | |
+22.40% | 1.21TCr | |
+27.49% | 1.21TCr |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- CureVac N : Plans To Sell Five Million Shares -- Stock Down 3% After-Hours